{"ABBV": {"Ticker": "ABBV", "Company": "AbbVie", "Sector": "Health Care", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$170"}, {"Date": "2022-11-08", "Rating": "Downgrade", "Organization": "Societe Generale", "Rating_Change": "Buy to Hold", "Target_Change": ""}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Credit Suisse", "Societe Generale"], "Price_Target": 170.0}, "AMGN": {"Ticker": "AMGN", "Company": "Amgen", "Sector": "Health Care", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Underperform", "Target_Change": "$240"}, {"Date": "2022-10-31", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$234"}, {"Date": "2022-10-11", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$257 to $279"}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Morgan Stanley", "Credit Suisse", "Barclays"], "Price_Target": 251.0}, "AMAT": {"Ticker": "AMAT", "Company": "Applied Materials", "Sector": "Information Technology", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-10-21", "Rating": "Upgrade", "Organization": "New Street", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2022-10-17", "Rating": "Initiated", "Organization": "William Blair", "Rating_Change": "Mkt Perform", "Target_Change": ""}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["New Street", "William Blair", "Summit Insights"], "Price_Target": 0}, "BMY": {"Ticker": "BMY", "Company": "Bristol Myers Squibb", "Sector": "Health Care", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$78"}, {"Date": "2022-10-10", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-09-14", "Rating": "Downgrade", "Organization": "Berenberg", "Rating_Change": "Buy to Hold", "Target_Change": "$82 to $76"}], "Score": -0.67, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Berenberg", "Credit Suisse", "Guggenheim"], "Price_Target": 77.0}, "CAG": {"Ticker": "CAG", "Company": "Conagra Brands", "Sector": "Consumer Staples", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$35 to $41"}, {"Date": "2022-11-15", "Rating": "Initiated", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform", "Target_Change": "$42"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Exane BNP Paribas", "UBS"], "Price_Target": 41.5}, "DPZ": {"Ticker": "DPZ", "Company": "Domino's Pizza", "Sector": "Consumer Discretionary", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Upgrade", "Organization": "Northcoast", "Rating_Change": "Neutral to Buy", "Target_Change": "$460"}, {"Date": "2022-10-11", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$460 to $430"}, {"Date": "2022-10-04", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$430 to $385"}, {"Date": "2022-09-23", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$430"}, {"Date": "2022-09-23", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Equal-Weight", "Target_Change": "$368"}, {"Date": "2022-09-08", "Rating": "Initiated", "Organization": "Bernstein", "Rating_Change": "Underperform", "Target_Change": "$334"}], "Score": 1.17, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "Stephens", "UBS", "BMO Capital Markets", "Bernstein", "Northcoast"], "Price_Target": 401.17}, "LLY": {"Ticker": "LLY", "Company": "Eli Lilly & Co", "Sector": "Health Care", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$395"}, {"Date": "2022-09-22", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$335 to $363"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Credit Suisse", "UBS"], "Price_Target": 379.0}, "HPQ": {"Ticker": "HPQ", "Company": "HP", "Sector": "Information Technology", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": ""}, {"Date": "2022-09-01", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": "$50 to $29"}], "Score": -1.5, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Credit Suisse", "Loop Capital"], "Price_Target": 29.0}, "JNJ": {"Ticker": "JNJ", "Company": "Johnson & Johnson", "Sector": "Health Care", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$170"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$175"}, {"Date": "2022-10-14", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$185 to $178"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["BofA Securities", "Credit Suisse", "Barclays"], "Price_Target": 174.33}, "MRK": {"Ticker": "MRK", "Company": "Merck & Co.", "Sector": "Health Care", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$120"}, {"Date": "2022-10-10", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2022-09-14", "Rating": "Upgrade", "Organization": "Berenberg", "Rating_Change": "Hold to Buy", "Target_Change": "$95 to $100"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Berenberg", "Credit Suisse", "Guggenheim"], "Price_Target": 110.0}, "PFE": {"Ticker": "PFE", "Company": "Pfizer", "Sector": "Health Care", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$55"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Credit Suisse"], "Price_Target": 55.0}, "PNW": {"Ticker": "PNW", "Company": "Pinnacle West Capital", "Sector": "Utilities", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Sell to Neutral", "Target_Change": "$54 to $70"}, {"Date": "2022-11-17", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Underperform to Peer Perform", "Target_Change": ""}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Guggenheim", "Wolfe Research"], "Price_Target": 70.0}, "ROST": {"Ticker": "ROST", "Company": "Ross Stores", "Sector": "Consumer Discretionary", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Upgrade", "Organization": "Gordon Haskett", "Rating_Change": "Hold to Buy", "Target_Change": "$130"}, {"Date": "2022-10-25", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$90 to $110"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Gordon Haskett", "Wells Fargo"], "Price_Target": 120.0}, "WBA": {"Ticker": "WBA", "Company": "Walgreens Boots Alliance", "Sector": "Consumer Staples", "Updated": "2022-11-18", "Rating": [{"Date": "2022-11-18", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$42"}, {"Date": "2022-11-11", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": ""}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["JP Morgan", "Deutsche Bank"], "Price_Target": 42.0}}